Search Ontology:
ChEBI

ilomastat

Term ID
CHEBI:137236
Synonyms
  • (2R)-N(4)-hydroxy-N(1)-[(2S)-3-(1H-indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl]-2-(2-methylpropyl)butanediamide
  • CS 610
  • galardin
  • GM 6001
  • GM-6001
  • GM6001
  • ilomastat
Definition
An N-acyl-amino acid obtained by formal condensation of the carboxy group of (2R)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoic acid with the amino group of N-methyl-L-tryptophanamide. A cell permeable broad-spectrum matrix metalloproteinase (MMP) inhibitor
References
  • cas:142880-36-2
  • kegg.drug:D03793
  • lincs.smallmolecule:LSM-3143
  • pdb-ccd:GM6
  • pubmed:12410973
  • pubmed:14568001
  • pubmed:15350544
  • pubmed:16565079
  • pubmed:16712832
  • pubmed:18782669
  • pubmed:18790756
  • pubmed:18837084
  • pubmed:19545667
  • pubmed:20299089
  • pubmed:20818082
  • pubmed:21040999
  • pubmed:21146503
  • pubmed:22512086
  • pubmed:22903888
  • pubmed:23141517
  • pubmed:23870824
  • pubmed:24380772
  • pubmed:24589605
  • pubmed:25576979
  • pubmed:26171681
  • pubmed:26394037
  • pubmed:27038494
  • pubmed:27112177
  • pubmed:27296149
  • pubmed:27708133
  • pubmed:27743382
  • pubmed:28297575
  • pubmed:28298987
  • pubmed:28417261
  • reaxys:7982373
  • wikipedia.en:Ilomastat
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
Phenotype
Phenotype resulting from ilomastat
Phenotype where environments contain ilomastat
Phenotype modified by environments containing ilomastat
Phenotype affecting ilomastat
Human Disease Model